Corbus Pharmaceuticals Correlations

CRBP Stock

USD 17.82 0.18 1.02%

The current 90-days correlation between Corbus Pharmaceuticals and ATyr Pharma is 0.07 (i.e., Significant diversification). The correlation of Corbus Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Corbus Pharmaceuticals Correlation With Market

Average diversification

The correlation between Corbus Pharmaceuticals Holding and DJI is 0.14 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Corbus Pharmaceuticals Holding and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Corbus Pharmaceuticals Holding. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Moving together with Corbus Stock

0.74	VALN	Valneva SE ADR	Pair Corr
0.85	VCNX	Vaccinex	Pair Corr
0.64	DRMA	Dermata Therapeutics	Pair Corr
0.76	DTIL	Precision BioSciences	Pair Corr
0.72	VINC	Vincerx Pharma	Pair Corr
0.83	VRAX	Virax Biolabs Group	Pair Corr
0.77	VRCA	Verrica Pharmaceuticals	Pair Corr
0.66	VRPX	Virpax Pharmaceuticals	Pair Corr
0.65	VTGN	VistaGen Therapeutics	Pair Corr

Moving against Corbus Stock

0.64	VERA	Vera Therapeutics	Pair Corr
0.59	DRUG	Bright Minds Biosciences Trending	Pair Corr
0.56	VCYT	Veracyte	Pair Corr
0.51	SABSW	SAB Biotherapeutics	Pair Corr
0.34	DMAC	DiaMedica Therapeutics Trending	Pair Corr
0.31	DSGN	Design Therapeutics	Pair Corr
0.72	VRDN	Viridian Therapeutics	Pair Corr
0.67	VRNA	Verona Pharma PLC	Pair Corr
0.6	VSTM	Verastem Trending	Pair Corr

Related Correlations Analysis

	LIFE	TRVI	CUE	ANTX	BCAB	KOD	GLMD	AFMD	MREO	ADVM
LIFE		0.25	-0.15	-0.56	0.05	-0.29	0.18	0.35	0.18	0.05	LIFE
TRVI	0.25		-0.38	-0.37	0.04	-0.63	0.6	0.38	0.51	0.33	TRVI
CUE	-0.15	-0.38		0.1	0.57	0.53	-0.46	-0.28	-0.15	0.56	CUE
ANTX	-0.56	-0.37	0.1		-0.3	0.64	-0.23	-0.43	-0.51	-0.44	ANTX
BCAB	0.05	0.04	0.57	-0.3		-0.19	-0.2	0.15	0.49	0.73	BCAB
KOD	-0.29	-0.63	0.53	0.64	-0.19		-0.43	-0.47	-0.77	-0.24	KOD
GLMD	0.18	0.6	-0.46	-0.23	-0.2	-0.43		0.18	0.04	0.01	GLMD
AFMD	0.35	0.38	-0.28	-0.43	0.15	-0.47	0.18		0.57	0.24	AFMD
MREO	0.18	0.51	-0.15	-0.51	0.49	-0.77	0.04	0.57		0.54	MREO
ADVM	0.05	0.33	0.56	-0.44	0.73	-0.24	0.01	0.24	0.54		ADVM
	LIFE	TRVI	CUE	ANTX	BCAB	KOD	GLMD	AFMD	MREO	ADVM

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ADVM	+ 0.73	BCAB
KOD	+ 0.64	ANTX
GLMD	+ 0.6	TRVI
BCAB	+ 0.57	CUE
MREO	+ 0.57	AFMD
ADVM	+ 0.56	CUE

High negative correlations

MREO	- 0.77	KOD
KOD	- 0.63	TRVI
ANTX	- 0.56	LIFE
MREO	- 0.51	ANTX
AFMD	- 0.47	KOD
GLMD	- 0.46	CUE

Risk-Adjusted Indicators

There is a big difference between Corbus Stock performing well and Corbus Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Corbus Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
LIFE	2.57	0.43	0.09	(1.47)	2.62	(3.23)	6.45	(5.29)	28.98
TRVI	3.08	(0.19)	(0.02)	0.02	3.66	(3.31)	6.59	(6.01)	17.04
CUE	7.64	1.31	0.19	1.54	5.80	(11.91)	20.27	(11.51)	67.78
ANTX	2.25	0.55	0.19	0.70	1.69	(3.91)	6.00	(2.83)	28.03
BCAB	4.44	(0.13)	(0.01)	0.04	4.78	(5.50)	12.86	(7.59)	31.41
KOD	3.14	1.20	0.44	0.67	2.26	(4.21)	9.70	(4.87)	18.79
GLMD	12.01	2.84	0.24	(10.65)	9.80	(21.44)	21.71	(13.40)	344.49
AFMD	2.72	(0.70)	0.00	(0.33)	0.00	0.00	7.25	(6.82)	21.26
MREO	2.72	(0.48)	0.00	(0.30)	0.00	0.00	4.80	(6.31)	17.36
ADVM	2.60	(0.22)	0.00	(0.01)	0.00	0.00	5.04	(6.81)	16.06

Corbus Pharmaceuticals Corporate Management

MD MA	Chief Officer	Profile
Christina Bertsch	Head Resources	Profile
CPA MBA	Chief Officer	Profile
Rachael Brake	Chief Officer	Profile
Lindsey Smith	Head Advocacy	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC